Centessa Pharmaceuticals plc (CNTA) Tops Q2 EPS by 22c
Tweet
Share
E-mail
Get Alerts CNTA Hot Sheet
Join SI Premium – FREE
Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Benchmark Reiterates Buy Rating on Malibu Boats (MBUU) on Significant Earnings Upside
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
